The company Ohio State University is enrolling patients into the clinical trial investigating Trial Comparing Three Single Dose Injections for Knee Osteoarthritis.
This study is a 3-arm, double-blind, randomized trial comparing the clinical outcomes of Zilretta, Synvisc One, and Monovisc for knee OA.
The trial is designed to enroll male and female 25 Years to 85 Years and is being conducted in the Jameson Crane Sports Medicine Institute, Columbus, Ohio, United States; Ohio State Outpatient Lewis Center, Lewis Center, Ohio, United States.
The study start date is August 2, 2022.
This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT05492851.